CN Stock MarketDetailed Quotes

600223 Lushang Freda Pharmaceutical

Watchlist
  • 6.95
  • +0.11+1.61%
Not Open Nov 19 15:00 CST
7.07BMarket Cap29.83P/E (TTM)

Lushang Freda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lushang Freda Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
877.19M
--
-4.82%
EPS
--
0.04
--
--
Analyst Rating
Strong Buy

Nov 19, 2024

Lushang Freda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.852B--
--2024/FY-- / 4.221B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.852B--
--2024/FY-- / 4.221B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--

Unlock Free Earnings Estimates

Lushang Freda Pharmaceutical Earnings Reports

  • Freda: Report of Lushang Freda Pharmaceutical Co., Ltd. for the third quarter of 2024

    Oct 28 12:00 ET

  • Announcement of Lushang Freda Pharmaceutical Co., Ltd. on the main operating data for the third quarter of 2024

    Oct 28 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 28 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. 2024 Interim Report

    Aug 23 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 19, 2024

    Strong Buy

    • Strong Buy

      67.65%

    • Buy

      32.35%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data